Bloomberg News and Videos — Page 256

"What the market wants to see is evidence that the Bank of Japan is not behind the curve on inflation," says Jane Foley, head of FX strategy at Rabobank, as the BOJ raised its benchmark interest rate by a quarter percentage point to 1%.

Jeff Currie, executive co-chairman at Abaxx Markets, says "the uncertainty remains quite high" around the Strait of Hormuz as maintaining the US-Iran ceasefire will be challenging. Currie looks at what the interim agreement means for the global oil market, what's behind the oil price drop, and how quickly Gulf nations can restore production.

London Mayor Sadiq Khan declined to back Keir Starmer to stay as UK prime minister until the next general election.

Anna Edwards, Guy Johnson, Tom Mackenzie and Mark Cudmore break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade."

While the anti-immigration One Nation party is gaining traction in opinion polls, Australian Prime Minister Anthony Albanese has resisted calls for deeper cuts to migrant intake. That's as Australia faces its own demographic pressures with the fertility rate at a record low. Roger Wilkins of the Melbourne Institute discusses the broader challenges and implications for Australia's future on 'Bloomberg: The Asia Trade.'

Lincoln Pan, CEO at Jardine Matheson Holdings, discusses the group's strategic blueprint that includes a share buyback, boosting returns and adding exposure to developed markets. He speaks exclusively on "Bloomberg: The China Show."

Japan's central bank increased its benchmark interest rate to the highest since 1995 and signaled that further policy normalization lies ahead. Bloomberg's Shery Ahn reports from Tokyo.

China's consumer spending contracted last month for the first time since the pandemic and investment deteriorated, exposing risks still facing the economy even as it benefits from booming exports and a deescalation in tensions around Iran. UBS Securities Chief China Economist Yu Song shares his analysis.

Biocon Executive Chairperson Kiran Mazumdar-Shaw says she is confident that the company's investment and capacity expansion in Insulin will make the company the top hub for the drug in the next five years. She speaks in an exclusive conversation with Bloomberg's Haslinda Amin.

John Rogers, Ariel Investments founder, chair, CIO and co-CEO, says MSG stocks have not reflected the value of the Knicks or the Rangers during an interview with Romaine Bostick and Katie Greifeld on "Bloomberg The Close."